We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-7.92%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$670M
AUM Growth
-$18.2M
Cap. Flow
-$299M
Cap. Flow %
-44.64%
Top 10 Hldgs %
86.43%
Holding
215
New
27
Increased
46
Reduced
57
Closed
68

Top Buys

Rank Stock Value
1
NRXP icon
NRX Pharmaceuticals
NRXP
+$2.55M
2
TANH icon
Tantech Holdings
TANH
+$2.24M
3
AGTC
Applied Genetic Technologies Corporation
AGTC
+$1.76M
4
ZVRA icon
Zevra Therapeutics
ZVRA
+$1.52M
5
NBEV
NewAge, Inc. Common Stock (Delaware)
NBEV
+$1.12M

Top Sells

Rank Stock Value
1
BTBT icon
Bit Digital
BTBT
+$17.7M
2
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$10.2M
3
ROI
RiskOn International, Inc. Common Stock
ROI
+$7.16M
4
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$5.75M
5
SLAI
SOLAI Ltd ADS
SLAI
+$5.55M

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.45%
2 Healthcare 7.54%
3 Technology 1.48%
4 Financials 0.56%
5 Consumer Discretionary 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MARA icon
176
PUT
Marathon Digital Holdings
MARA
$4.34B
– –
-1,997
Closed -$6.56M
NCTY
177
CALL
The9 Ltd
NCTY
$60.8M
– –
-12
Closed -$82K
PALI icon
178
Palisade Bio
PALI
$352M
– –
-70
Closed -$68K
PDSB icon
179
CALL
PDS Biotechnology
PDSB
$32.8M
– –
-933
Closed -$756K
PDSB icon
180
PUT
PDS Biotechnology
PDSB
$32.8M
– –
-376
Closed -$305K
PMCB icon
181
CALL
PharmaCyte Biotech
PMCB
$4.1M
– –
-431
Closed -$108K
RCAT icon
182
CALL
Red Cat Holdings
RCAT
$1.22B
– –
-312
Closed -$65K
RCAT icon
183
Red Cat Holdings
RCAT
$1.22B
– –
-1,350,589
Closed -$2.81M
RIOT icon
184
Riot Platforms
RIOT
$7.39B
– –
-199,064
Closed -$4.45M
RIOT icon
185
PUT
Riot Platforms
RIOT
$7.39B
– –
-2,183
Closed -$4.88M
RKDA icon
186
Arcadia Biosciences
RKDA
$1.04M
– –
-6,330
Closed -$302K
BNKK
187
Bonk Inc
BNKK
$10.2M
– –
-2,721
Closed -$85K
SWAG icon
188
Stran & Co
SWAG
$30.6M
– –
-750,000
Closed -$4.54M
UK icon
189
Ucommune International Ltd Class A Ordinary Shares
UK
$1.36M
– –
-42
Closed -$69K
VANI icon
190
Vivani Medical
VANI
$111M
– –
-163,991
Closed -$802K
VANI icon
191
PUT
Vivani Medical
VANI
$111M
– –
-711
Closed -$348K
VXX icon
192
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$132M
– –
-15,625
Closed -$5.75M
XNTK icon
193
PUT
State Street SPDR NYSE Technology ETF
XNTK
$1.87B
– –
-628
Closed -$7.03M
ALPP
194
DELISTED
Alpine 4 Holdings Inc
ALPP
– –
-2,526
Closed -$30.9K
POL
195
DELISTED
Polished.com Inc.
POL
– –
-6,150
Closed -$738K
POL
196
PUT
DELISTED
Polished.com Inc.
POL
– –
-88
Closed -$1.05M
ROI
197
DELISTED
RiskOn International, Inc. Common Stock
ROI
– –
-1,070
Closed -$7.16M
DMK
198
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
– –
-5
Closed -$19K
MRTX
199
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-193
Closed -$2.83M
NMRD
200
PUT
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
– –
-275
Closed -$125K
5 6 7
8
9

Similar funds

IWA
Independent Wealth Advisors Cary, North Carolina $111M AUM
BFA
Ballast Financial Advisors West Chester, Pennsylvania $110M AUM
WPWM
Western Pacific Wealth Management Lake Forest, Illinois $111M AUM 26.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
ZS
Zenith Solutions Philadelphia, Pennsylvania $110M AUM
KC
Karras Company Roy, Utah $110M AUM
FI
FinArc Investments Norwood, Massachusetts $110M AUM
CIM
Catalyst Investment Management Windham, New Hampshire $110M AUM

Sabby Management's Q1 2022 Portfolio in Review

As of Q1 2022, Sabby Management held 215 positions worth $670M, down 2.6% from $688M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Sabby Management withdrew a net $299M in Q1 2022, closing 68 positions and reducing 57 holdings. Its most notable exit was Bit Digital, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 88% of assets, up from 75% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Sabby Management opened a new position in NRX Pharmaceuticals worth $1.92M.

  • Sabby Management's largest Q1 2022 buy was NRX Pharmaceuticals: 78,247 shares worth $1.92M.
  • Sabby Management added most to Tantech Holdings in Q1 2022, an estimated $2.24M increase.
  • Sabby Management's biggest Q1 2022 reduction was SOLAI Ltd ADS, cutting an estimated $5.55M.
  • Sabby Management fully exited Bit Digital in Q1 2022, selling an estimated $17.7M.
  • Sabby Management's ten largest holdings make up 86% of its $670M portfolio in Q1 2022.
  • Sabby Management opened 27 new positions and closed 68 in Q1 2022.
  • Sabby Management's portfolio value fell 2.6% quarter-over-quarter to $670M.

Based on Sabby Management's 13F filing for Q1 2022, filed 16 May 2022.